Welcome to the e-CCO Library!

P396: COVID-19 pandemic-related endoscopy delays did not translate to deleterious outcomes for patients with Inflammatory Bowel Disease: A retrospective cohort study
Year: 2022
Source: ECCO'22
Authors: Chambers, J.(1);Gurpreet, M.(1);Maria, M.(1);Reena, K.(1);Aze Suzanne, W.(1);
Created: Friday, 11 February 2022, 3:52 PM
P396: Cyclosporin A efficacy in a paediatric ulcerative colitis: a retrospective single-centre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Osiecki*, M. Dadalski, J. Kierkus

Created: Friday, 22 February 2019, 9:49 AM
P396: Long-term efficacy of thiopurines as maintenance treatment in 130 patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Lefevre C., Fotsing G., Wangermez M., Beau P.

Created: Wednesday, 20 February 2019, 10:36 AM
P396: Monitoring adalimumab compliance using smart sharp bin technology
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Hazel*1, C. Smyth1, O. Kelly1, R. J. Farrell1

Created: Friday, 22 February 2019, 9:41 AM
P396: Pharmacokinetics, immunogenicity and clinical outcomes of golimumab from the PURSUIT PEDS ulcerative colitis study long-term (through week 126) extension
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Hyams1, C.D. O’Brien2, L. Padgett2, J. Rosh3, D. Turner4, G. Veereman5, A. Griffiths6, M.B. Heyman7, G. Wahbeh8, J. Adedokun2, R. Strauss2, D. Chan2, J. Lynch2*

Created: Thursday, 21 February 2019, 9:14 AM
P396: Ustekinumab Is A Promising Option For The Treatment Of Postoperative Recurrence Of Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Macaluso, F.S.(1)*;Grova, M.(1);Mocciaro, F.(2);Di Mitri, R.(2);Privitera, A.C.(3);Distefano, M.E.(3);Vitello, A.(4);Camilleri, S.(4);Ferracane, C.(5);Pluchino, D.(5);Belluardo, N.(6);Giangreco, E.(6);Fries, W.(7);Viola, A.(7);Cappello, M.(8);Amato, L.(8);Bertolami, C.(9);Ventimiglia, M.(10);Renna, S.(1);Casà, A.(1);De Vivo, S.(1);Orlando, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P397 Surveillance in ulcerative colitis: Can we predict the risk for intraepithelial neoplasia?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Estorninho1, P. Freire2, S. Lopes1, M. Ferreira1, M. Ferreira1, F. Portela1, P. Figueiredo1

Created: Thursday, 30 January 2020, 10:12 AM
P397: Advanced therapy persistence and need for dose optimisation in a cohort of Inflammatory Bowel Disease patients in Argentina: a real-world evidence multicenter study (REMAR study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Lasa, J.(1)*;Nazario, E.(2);Zubiaurre, I.(2);Rausch, A.(2);Hermida, R.(3);Cassella, F.(4);Marzullo, S.(4);Suarez Pellegrino, A.(5);Deborah, B.(5);Toro, M.(5);Novillo, A.(6);Omodeo, J.(6);Tirado, P.(7);Bellicoso, M.(7);Olivera, P.(8);Balderramo, D.(9);Torello, R.(9);Chiaraviglio, L.(9);Scacchi, A.(3);Linares, M.(10);Gonzalez, R.(11);Bentolila, F.(11);Lubrano, P.(12);Quintero, O.(10);De Paula, J.(13);Gonzalez Sueyro, R.(13);Sanchez, B.(13);Fuxman, C.(14);Velazquez , A.(15);
Created: Friday, 14 July 2023, 11:05 AM
P397: Approach and management of psychological aspects of inflammatory bowel disease described by patients and physicians in Spain. The ENMENTE Project
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Marín-Jiménez I.*1, Panadero A.2, Gobbo Montoya M.3, Cañas M.4, Modino Y.5, Guardiola J.6, Cea-Calvo L.7, Juliá B.7, Romero C.7, Carmona L.8, Barreiro-de Acosta M.9

Created: Wednesday, 20 February 2019, 10:36 AM
P397: Autologous stem cell transplantation in refractory Crohn's disease: evaluation of a modified mobilisation regimen and analyses of the cost-effectiveness
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

N. Mahmmod*1, S. Mahmmod2, M. Severs2, H. Koene3, F. van Wijk4, B. Oldenburg2, H. Fidder2

Created: Friday, 22 February 2019, 9:41 AM
P397: Can upskilling pharmacy technicians support a robust and cost-effective Inflammatory Bowel Disease patient review process? A single-centre prospective study.
Year: 2022
Source: ECCO'22
Authors: Rees, F.(1);Packham, A.(1);St Clair Jones, A.(1);Smith, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P397: Effectiveness of vedolizumab (VDZ) for the induction of remission in inflammatory bowel disease (IBD): Results from the Spanish Eneida Registry
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Chaparro1,2,3,4*, A. Garre1,2,3,4, I. Alfaro4,5, M. Iborra4,6, P. Mesonero7, I. Vera Mendoza8, A. Rodríguez9, J. Miquel-Cusachs10, S. Riestra11, P. Navarro12, L. De Castro Parga13, C. González-Muñoza14, M. Rivero15, M. Mañosa4,16, L. Fernández Salazar17, N. Jiménez18, J. Guardiola19, J. Cabriada20, A. Gutiérrez Casbas4,21, B. Sicilia22, J.L. Pérez Calle23, M. Piqueras24, A. Algaba25, O. Roncero26, A. Bargallo27, E. Sainz28, J. Barrio29, X. Calvet4,30, A. García31, M. Llorente Barrio32, R. Llorente Poyatos33, P. Almela34, R. Madrigal35, A.J. Lucendo Villarín36, R. Pajares37, M. Van Domselaar38, J. Legido Gil39, J.P. Gisbert1,2,3,4

Created: Thursday, 21 February 2019, 9:14 AM
P397: Efficacy and safety of sequential rescue therapy with infliximab and tacrolimus in patients with corticosteroid-refractory ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. Matsuoka*, E. Saito, T. Fujii, K. Takenaka, F. Iwamoto, M. Kimura, M. Nagahori, K. Ohtsuka, M. Watanabe

Created: Friday, 22 February 2019, 9:49 AM
P397: Response to biologics in IBD patients assessed by Computerized image analysis of Probe Based Confocal Laser Endomicroscopy with molecular labeling
Year: 2021
Source: ECCO'21 Virtual
Authors: Iacucci, M.(1);Grisan, E.(2);Labarile, N.(1);Nardone, O.(1);Smith, S.C.(1);Jeffery, L.(1);Ghosh, S.(1);Buda, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P398 The early appearance of anti-drug antibodies during the induction phase predicts the clinical response of adalimumab and infliximab in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

X. Roblin1, N. williet1, P. veyrard1, G. boschetti2, A.E. berger3, S. nancey2, B. flourie2, S. paul3

Created: Thursday, 30 January 2020, 10:12 AM
P398: An objective measure of response to treatment for patients with Crohn's perianal fistulas on anti-TNF treatment
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sahnan K.*1, Lung P.F.2, Adegbola S.O.1, Burling D.2, Burn J.2, Tozer P.J.1, Gupta A.2, Faiz O.D.1, Phillips R.K.1, Hart A.L.3

Created: Wednesday, 20 February 2019, 10:36 AM
P398: Cannabis induces clinical and endoscopic improvement in moderately active ulcerative colitis (UC)
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Naftali1,2*, L. Bar Lev Schlieder3, F. Sklerovsky Benjaminov1,2, I. Lish2,4, J. Hirsch4, F.M. Konikoff1,2

Created: Thursday, 21 February 2019, 9:14 AM
P398: Disease clearance: a potential target for management of patients with Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Andronic, A.M.(1)*;Toader, E.(1);
Created: Friday, 14 July 2023, 11:05 AM
P398: Effect of Intravenous versus Oral Iron Therapy on Physical Fitness and Haemoglobin in Paediatric IBD Patients with Anaemia
Year: 2021
Source: ECCO'21 Virtual
Authors: Bevers, N.(1);van de Vijver , E.(2);Aliu , A.(1);Rezazadeh Ardabili , A.(3);Rosias , P.(1);Busari , J.(4);Stapelbroek , J.(5);Bertrams , I.(6); van der Feen , C.(7);Oudshoorn , A.(8);Teklenburg , S.(9);Escher , J.(10);Vande Velde , S.(11);Winkens , B.(12);Raijmakers , M.(13);Vreugdenhil , A.(14); Pierik , M.(3);van Rheenen , P.(15);
Created: Wednesday, 2 June 2021, 4:12 PM
P398: Leptin controls immune cell composition and activity in acquired generalised lipodystrophy with combined Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. F. Ziegler*1, C. Böttcher2, H. Wu1, R. Glauben1, B. Siegmund1, C. Weidinger1,3

Created: Friday, 22 February 2019, 9:41 AM